�Bullet� Virus to Fight Cancer, HIV?

Vesicular stomatitis virus has long been a model system for studying and understanding the life cycle of negative-strand RNA viruses, which include viruses that cause influenza, measles, and rabies.

More importantly, though, research has shown that VSV has the potential to be genetically modified to serve as an anticancer agent, exercising high selectivity in killing cancer cells while sparing healthy cells, and as a potent vaccine against HIV.

For such modifications to occur, however, scientists must have an accurate picture of the virus's structure. While three-dimensional structural information of VSV's characteristic bullet shape and its assembly process has been sought for decades, efforts have been hampered by technological and methodological limitations.

Now, researchers at the University of California, Los Angeles, NanoSystems Institute and the department of microbiology, immunology, and molecular genetics and colleagues have not only revealed the 3-D structure of the trunk section of VSV but also further deduced the architectural organization of the entire bullet-shaped virion through cryo-electron microscopy and an integrated use of image-processing methods.

Their research findings appear this month in the journal Science.

"Structures of individual rhabdovirus proteins have been reported in Science and other high-profile journals, but until now, how they are organized into a bullet shape has remained unclear," said study author Z. Hong Zhou, UCLA professor of microbiology, immunology, and molecular genetics and a member of the CNSI. "The special shape of VSV -- a bullet head with a short, helical trunk -- has lent to its evasion from three-dimensional structural studies."

Based on their research into the structure of VSV, the team proposed a model for the assembly of the virus, with its origin at the bullet tip. Their data suggest that VSV assembles through the alternating use of several possible interaction interfaces coded in viral protein sequences to wind its protein and RNA chain into the characteristic bullet shape.

The findings could help lead to advances in the development of VSV-based vaccines for HIV and other deadly viruses, according to the researchers.

"Our structure provides some of the first clues for understanding VSV-derived vaccine pseudotypes and for optimizing therapeutic VSV variants," Zhou said. "This work moves our understanding of the biology of this large and medically important class of viruses ahead in a dramatic way. The next stage of research for our team will be to reveal the details of molecular interactions at the atomic scale using advanced imaging instruments now available at CNSI."